A TLR7 agonist enhances the anti-tumor efficacy of...

Leukemia 2016 / 11

A TLR7 agonist enhances the anti-tumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

Cheadle, E J, Lipowska-Bhalla, G, Dovedi, S J, Fagnano, E, Klein, C, Honeychurch, J, Illidge, T M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Leukemia
DOI:
10.1038/leu.2016.352
Date:
November, 2016
File:
PDF, 1.88 MB
english, 2016
Conversion to is in progress
Conversion to is failed